Carlyle's Q2 2026 Report Is Today - the Last Headline Is a Year Old

The headline you're seeing about Carlyle's second-quarter profit jump is from August 2025 - a full year ago. The company's Q2 2026 results are scheduled for release today, August 5, at 8:30 a.m. ET. The stock has been bid up 15% over the past three weeks ahead of that report. Before buying into the narrative, it's worth checking what the factor stack actually says about the setup.

Carlyle (CG) is trading at $50.64, up 3.5% on the day. That's still about 27.5% below its 52-week high of $69.85 and down 14.3% year-to-date. The recent 20-day rally to +15% and five-day pop of +9% have pushed the RSI to 69.7 - near the overbought threshold. The momentum is there. The question is whether the underlying metrics justify the bid or whether the stock is front-running a recovery the earnings haven't confirmed yet.

Valuation: Forward-looking, but trailing numbers haven't caught up

Carlyle trades at 33.4x trailing earnings, 20.3x forward earnings, 2.47x book value, and 29.6x EV/EBITDA. The trailing multiple looks rich because realized gains - the one-off profits from selling portfolio companies - crashed in 2026 as the exit environment tightened. But that's exactly how private equity accounting works: revenue swings violently with realization timing, not with the health of the underlying fee engine. The forward P/E of 20.3x implies analysts expect a reversion to higher-normal earnings as dealmaking reaccelerates. Priced in or not, that forward multiple is the one that matters for valuation right now, not the trailing number distorted by a realization trough.

The dividend adds a 2.76% yield, paid for 13 consecutive years. But the payout ratio sits at 92%, leaving almost no cushion if distributable earnings soften further. That's a durability question, not a breaking point - yet.

Growth and Profitability: Fee engine is the real story, not headline revenue

Reported revenue growth is -28.9% year-over-year. That number looks terrible on a screen and is exactly why the stock fell. But for a private equity firm, headline revenue is lumpy - it blends steady fund management fees with volatile transaction fees and realized gains. The metric that matters more is fee-related earnings (FRE), the portion of profit that comes from ongoing management fees and incentive allocations rather than one-off exits.

In Q1 2026, Carlyle posted FRE of $300 million at a 47% margin, up from $290 million in the prior quarter. Fund management fees grew 4% year-over-year to $545 million, driven by AlpInvest (its secondary buyout unit, now at $107 billion AUM) and global credit ($209 billion AUM). The fee engine is expanding. Operating margin sits at 22.1% and EBITDA margin at 26.9%. Those aren't spectacular for a high-fixed-cost asset manager, but they're stable, and stability matters when the realization cycle is down.

ROE is 9.95%. ROIC is 3.86%. Neither grade is top-quartile. But ROIC is notoriously compressed for private equity firms during realization troughs because the denominator (capital employed) stays high while the numerator (operating profit) gets dinged by non-recurring expenses. It's a cyclical distortion, not a structural deterioration.

Safety: Levered, but that's the business model

Debt-to-equity stands at 191.9%, with $22.5 billion of total debt against $7.4 billion of equity. That looks alarming for a public company but is standard for a private equity platform - Carlyle uses leverage on its balance sheet the way its portfolio companies do, deploying borrowed capital to scale investments. The real safety question is liquidity: $2.75 billion in cash. Free cash flow TTM is deeply negative (-$4.28 billion) and FCF growth is -227.5% year-over-year. Both figures are dragged by large realized-loss write-downs and fund redemptions, not by operating weakness. Still, the safety factor grades low by mechanical screeners, and that keeps institutional buyers cautious.

Momentum and the M&A backdrop

The momentum story is the only factor that's clearly positive. The stock has rallied 15% in 20 days and nearly 9% in five, trading above its 50-day moving average ($44.65) but still below the 200-day ($51.67). The MACD is positive at 0.94. Short-term buyers are positioning for the Q2 report, anticipating stronger transaction fees and realizations from a dramatically improved dealmaking environment.

The M&A backdrop supports that thesis. U.S. corporate deal value in the first five months of 2026 was nearly double the same period a year ago - $1.2 trillion versus $603 billion, even as deal volume dipped slightly. PwC projects 94 megadeals of $5 billion or more this year. For a firm like Carlyle, whose transaction fees and future carry both depend on deal flow, that's a direct tailwind. Carlyle disclosed in July the $2.6 billion sale of Copia Power to EQT, returning more than five times the firm's original investment. That's the kind of realization that analysts are hoping to see scale in Q2.

But the macro environment isn't uniformly supportive. The Federal Reserve held rates steady at 3.50%–3.75% in mid-June and removed its easing bias. Inflation sits at 4.1% headline, above the Fed's 2% target. Private market reports from Q2 flag heightened selectivity, tighter credit in older vintages, and concentrated stress in 2021–2022 software deals. The exit environment is improving but not back to 2021 levels.

What the Q2 consensus expects

Analysts are calling for $0.91 in distributable EPS and roughly $923 million in revenue for Q2. Those are modest targets coming off a Q1 that missed on both lines ($0.89 actual EPS versus $0.91 expected, $750.9 million revenue). The consensus isn't demanding much - but the stock's 15% pre-earnings run suggests investors are pricing in more than a simple beat. A Q2 that merely meets expectations won't extend the rally. A beat on fee-related earnings - specifically transaction fees growing meaningfully from Q1's $54 million - would give the momentum its fundamental anchor.

The cross-check

AInvest's aggregate signal labels Carlyle a Hold, with a composite analysis rating of 2.74 and a fundamental rating of 4.88 out of 10. That's not a bearish verdict, but it's not bullish either. It says the stock's fundamental metrics haven't yet cleared the threshold for a Buy signal, consistent with a name sitting between a Q1 miss and an unconfirmed Q2 turnaround.

What to watch

Today's Q2 report will separate the pre-earnings bid from the fundamental reality. Three numbers matter most:

1. Fee-related earnings - Did transaction fees grow materially from Q1's $54 million? That's the direct read on whether the M&A tailwind is flowing into Carlyle's revenue.
2. Realizations - Was the Copia Power exit the start of a pipeline or a one-off? Record returns to U.S. buyout investors in Q1 set a high bar.
3. Guidance tone - Any revision to the full-year FRE outlook would matter more than the quarterly headline. Carlyle's Q1 management commentary was confident; Q2 needs to match it.

Portfolio positioning

Carlyle fits a growth sleeve focused on the M&A recovery trade. It's not an income name despite the dividend - the 92% payout ratio leaves no margin of safety. It's not a value name at 33.4x trailing earnings. It's a momentum play on the fee engine reaccelerating, and it belongs in a portfolio alongside other alternative asset managers if you're betting on private credit growth and deal flow normalization.

The factor stack heading into today: momentum is A-, valuation is C+ (forward only), growth is D+ (fee engine strong, headline lumpy), profitability is C, and safety is D. Three factors lean positive, two are weak. That's a Hold on balance - the Q2 report is what tips it.

The last headline about Carlyle's Q2 profit was from a year ago. Today's numbers will write a new one.